Iterum Therapeutics plc
Iterum Therapeutics plc (ITRM) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 142 transactions totaling $109.0M, demonstrating a bullish sentiment with $6.1M in net insider flow. The most recent transaction on Nov 18, 2025 involved a purchase of 6,000 shares valued at $2.2K.
ITRM Insider Activity Summary
Who Is Buying ITRM Stock?
No significant insider buying has been recorded for ITRM in the recent period.
Who Is Selling ITRM Stock?
No significant insider selling has been recorded for ITRM in the recent period.
Is Iterum Therapeutics plc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ITRM is bullish with an Insider Alignment Score of 53/100 and a net flow of $6.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ITRM Frequently Asked Questions
Understanding ITRM Insider Activity
Insider trading at Iterum Therapeutics plc (ITRM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading ITRM stock, having executed 142 transactions in the past 90 days. The most active insider is Capital Catapult Fund Llc Sarissa (Executive), who has made 3 transactions totaling $50.0M.
Related Tools
Track Iterum Therapeutics plc Insider Activity
Get notified when executives and directors at ITRM file new Form 4 transactions